MR

Mukesh Rameshbhai Patel

Active Director Director DIN 10901926
DIN 10901926 First appointment Jan 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Mukesh Rameshbhai Patel

Data last updated:

Mukesh Rameshbhai Patel is a Director at Fenclay Lifesciences Private Limited (since 2025). The company operates in Pharma.

DIN 10901926
Primary Designation Director
Industry Pharma
First Appointment 09 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Fenclay Lifesciences Private Limited U46497GJ2025PTC157773
Director09 Jan 20252025Active

Board colleagues of Mukesh Rameshbhai Patel

NameDINCompanyDesignation
Kautilya Patel10901925Fenclay Lifesciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Fenclay Lifesciences Private Limited
Premium access

Shareholding and investment profile for Mukesh Rameshbhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mukesh Rameshbhai Patel

Mukesh Rameshbhai Patel currently holds 1 directorship: Fenclay Lifesciences Private Limited (Director, since 09 Jan 2025).

Mukesh Rameshbhai Patel was first appointed on 09 Jan 2025 as Director at Fenclay Lifesciences Private Limited.

The current boards of Mukesh Rameshbhai Patel's companies include Kautilya Patel (Fenclay Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available